Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nidda Healthcare Holding GmbH is the German holding entity for STADA Arzneimittel AG, one of Europe’s largest generics and consumer healthcare companies. STADA operates globally with a broad portfolio across Generics, Specialty pharmaceuticals, and Consumer Healthcare, supplying products to around 115 countries. The company is not dependent on any single product or therapeutic area, and its growth is driven by a combination of organic expansion, acquisitions, and partnerships. Financial performance is robust, with 2024 sales projected at €4 billion and EBITDA around €900 million. Specialty is the fastest-growing segment, driven by launches in biosimilars and innovative therapies for chronic and rare diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nidda Healthcare Holding.